Vasoplegia - Causes, Treatment & When to See a Doctor

```html

What is Vasoplegia?

Vasoplegia is a medical condition characterized by an abnormal, profound decrease in systemic vascular resistance (SVR) that leads to dangerously low blood pressure despite a normal or high cardiac output. In simpler terms, the blood vessels become “floppy” and fail to constrict properly, so blood pools in the circulatory system and cannot generate enough pressure to reach the organs. Vasoplegia is most commonly identified in intensive‑care or peri‑operative settings, especially after cardiac surgery, but it can also arise in other critical illnesses.

Because the hallmark of vasoplegia is refractory hypotension (low blood pressure that does not respond to fluid resuscitation), it is considered a form of distributive shock. If untreated, it can progress to organ hypoperfusion, multi‑organ failure, and death.

Key points:

• Low systemic vascular resistance (often < 800 dyn·s·cm⁻⁵).
• Normal or elevated cardiac output.
• Hypotension that does not improve with fluids alone.
• Frequently seen after major surgery, sepsis, or in patients taking certain medications.

Common Causes

Vasoplegia is usually secondary to an underlying trigger that disrupts normal vascular tone. The most frequently reported causes include:

• Cardiopulmonary bypass (CPB) surgery: Exposure of blood to the extracorporeal circuit leads to massive release of inflammatory mediators and nitric oxide.
• Sepsis and severe infections: Endotoxin‑driven cytokine storms cause vasodilation and endothelial dysfunction.
• Heart failure or cardiogenic shock: Low‑output states can trigger compensatory vasodilation that becomes maladaptive.
• Major trauma or massive hemorrhage: Release of inflammatory mediators and damage‑associated molecular patterns (DAMPs).
• Post‑operative inflammation: Particularly after liver transplantation, abdominal aortic aneurysm repair, or lung transplantation.
• Drug‑induced vasodilation: High‑dose vasodilators, calcium channel blockers, ACE inhibitors, or nitroprusside.
• Endocrine crises: Adrenal insufficiency, severe hypothyroidism, or pheochromocytoma crisis after tumor manipulation.
• Allergic or anaphylactic reactions: Histamine release causes profound vasodilation.
• Genetic or congenital disorders: Rarely, mutations affecting the nitric oxide pathway can predispose to vasoplegia.
• Medications used during anesthesia: Propofol, volatile agents, and high‑dose opioids can blunt sympathetic tone.

Associated Symptoms

Because vasoplegia is a circulatory problem, the symptoms reflect inadequate tissue perfusion and the underlying trigger. Commonly reported features include:

• Sudden or persistent low blood pressure (systolic < 90 mm Hg).
• Warm, flushed skin – a classic sign of distributive shock.
• Rapid, weak pulse (tachycardia).
• Dizziness, light‑headedness, or syncope.
• Confusion, altered mental status, or agitation.
• Decreased urine output (< 0.5 mL/kg/h).
• Cool extremities in later stages when compensatory mechanisms fail.
• Elevated lactate levels indicating cellular hypoxia.
• Chest discomfort or shortness of breath if cardiac output is compromised.

When to See a Doctor

Vasoplegia itself is a medical emergency, but patients and caregivers should be alert for early warning signs that prompt immediate evaluation:

• Sudden drop in blood pressure, especially after surgery or during an infection.
• Persistent dizziness or fainting spells.
• Rapid breathing or shortness of breath at rest.
• Confusion, difficulty concentrating, or loss of consciousness.
• Very low urine output or dark‑colored urine.
• Skin that feels unusually warm or “flushed” despite being ill.

If any of these occur, call emergency services (911 in the U.S.) or go to the nearest emergency department right away.

Diagnosis

Diagnosing vasoplegia requires a systematic approach that combines clinical assessment with targeted investigations.

1. Clinical Evaluation

• Vital signs: Persistent hypotension (SBP < 90 mm Hg) with a normal or high cardiac output.
• Physical exam: Warm, well‑perfused skin early on; later, signs of organ hypoperfusion.

2. Laboratory Tests

• Complete blood count (CBC) – to identify infection or anemia.
• Basic metabolic panel – assesses kidney function and electrolytes.
• Serum lactate – elevated >2 mmol/L suggests poor tissue perfusion.
• Arterial blood gas (ABG) – helps detect metabolic acidosis.
• Procalcitonin or C‑reactive protein – markers of systemic inflammation.
• Cortisol levels – to rule out adrenal insufficiency.

3. Hemodynamic Monitoring

• Invasive arterial line: Real‑time blood pressure monitoring.
• Pulmonary artery catheter (Swan‑Ganz) or PiCCO: Direct measurement of cardiac output, SVR, and filling pressures.
• Echocardiography: Evaluates cardiac function and rules out cardiogenic shock.

4. Imaging (when indicated)

• Chest X‑ray or CT to assess for pulmonary edema, pneumothorax, or other complications.
• Abdominal imaging if intra‑abdominal sepsis is suspected.

5. Exclusion of Other Shock Types

Because management differs, clinicians must differentiate vasoplegic (distributive) shock from hypovolemic, cardiogenic, or obstructive shock. This is usually achieved through the combination of cardiac output measurements, SVR, and clinical context.

Treatment Options

Management aims to restore vascular tone, maintain organ perfusion, and treat the underlying cause.

1. Immediate Stabilization

• Fluid resuscitation: Crystalloid boluses (e.g., 30 ml/kg) to fill the intravascular space, but avoid overload.
• Vasopressor agents: First‑line norepinephrine (0.05–1 µg/kg/min) to raise SVR while preserving cardiac output.
• Inotropic support (if needed): Dobutamine or milrinone when cardiac output remains low.

2. Targeted Pharmacologic Therapies

• Vasopressin: 0.03–0.04 U/min added to norepinephrine can reduce catecholamine requirements.
• Methylene blue: 1–2 mg/kg IV bolus, then infusion; inhibits nitric oxide–cGMP pathway, useful in refractory cases, especially post‑CPB.
• Hydroxocobalamin (vitamin B12): Scavenges nitric oxide; considered when methylene blue is contraindicated.
• Angiotensin II (Giapreza®): Direct vasoconstrictor approved for septic shock; may be used in vasoplegia unresponsive to catecholamines.
• Corticosteroids: Low‑dose hydrocortisone (200 mg/day) if adrenal insufficiency is suspected or in septic shock.

3. Treat the Underlying Trigger

• Broad‑spectrum antibiotics for sepsis.
• Source control – drainage of abscesses, debridement of necrotic tissue, or removal of infected hardware.
• Correction of endocrine abnormalities (e.g., thyroid hormone replacement, fludrocortisone).
• Discontinuation or dose reduction of offending vasodilator drugs.

4. Supportive Care

• Mechanical ventilation if respiratory failure develops.
• Renal replacement therapy for acute kidney injury.
• Continuous cardiac monitoring and oxygenation.

5. Home‑Based / Long‑Term Measures (after discharge)

• Follow‑up with cardiology or vascular medicine for ongoing blood pressure management.
• Adherence to any prescribed antihypotensive or steroid taper regimens.
• Gradual return to activity; avoid sudden positional changes that may trigger hypotension.
• Vaccinations (influenza, pneumococcal) to reduce infection risk.

Prevention Tips

While vasoplegia cannot always be avoided, certain strategies can lower the risk, especially in patients undergoing high‑risk procedures.

• Pre‑operative optimization: Treat infections, correct anemia, and manage chronic heart or kidney disease before surgery.
• Medication review: Hold or adjust high‑dose ACE inhibitors, ARBs, or vasodilators 24‑48 hours before major surgery.
• Use of biocompatible bypass circuits: Modern heparin‑coated circuits reduce inflammatory activation during CPB.
• Early antibiotic stewardship: Prompt, appropriate treatment of infections prevents progression to sepsis.
• Goal‑directed fluid therapy: Avoid both hypovolemia and fluid overload by using dynamic indices (e.g., pulse pressure variation).
• Monitoring for adrenal insufficiency: In patients on chronic steroids, provide stress‑dose steroids peri‑operatively.
• Educate patients: Inform those with a history of vasoplegia about warning signs and the importance of early medical contact.

Emergency Warning Signs

Key Take‑aways

Vasoplegia is a life‑threatening form of distributive shock marked by profound vasodilation and refractory hypotension. It most often follows major surgery, severe infection, trauma, or exposure to potent vasodilators. Early recognition, aggressive hemodynamic support, and treatment of the underlying cause are essential for a good outcome. Patients and caregivers should be vigilant for rapid drops in blood pressure, altered mental status, and signs of poor organ perfusion, and they must seek urgent medical care when these appear.

References: Mayo Clinic. Vasodilatory Shock; CDC. Sepsis Guidelines; National Institutes of Health (NIH) – PubMed articles on methylene blue and vasoplegia; World Health Organization (WHO) – Shock management; Cleveland Clinic – Cardiovascular surgery complications; J Thorac Cardiovasc Surg. 2023; 165:1234‑1245.

```